Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Similar articles for PubMed (Select 23355550)

1.

Authors' response: Metformin and risk of hepatocellular carcinoma--a study focused on anti-diabetic agents.

Wu CY, Chen HP.

Gut. 2013 Jun;62(6):952. doi: 10.1136/gutjnl-2012-304319. Epub 2013 Jan 26. No abstract available.

PMID:
23355550
2.

Metformin and risk of hepatocellular carcinoma: are statins the missing link?

Singh S, Singh PP.

Gut. 2013 Jun;62(6):951-2. doi: 10.1136/gutjnl-2012-304232. Epub 2012 Dec 22. No abstract available.

PMID:
23263525
3.

Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies.

Chen HP, Shieh JJ, Chang CC, Chen TT, Lin JT, Wu MS, Lin JH, Wu CY.

Gut. 2013 Apr;62(4):606-15. doi: 10.1136/gutjnl-2011-301708. Epub 2012 Jul 7.

PMID:
22773548
4.

Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease.

Donadon V, Balbi M, Mas MD, Casarin P, Zanette G.

Liver Int. 2010 May;30(5):750-8. doi: 10.1111/j.1478-3231.2010.02223.x. Epub 2010 Mar 12.

PMID:
20331505
5.

Hyperinsulinemia and risk for hepatocellular carcinoma in patients with chronic liver diseases and Type 2 diabetes mellitus.

Donadon V, Balbi M, Zanette G.

Expert Rev Gastroenterol Hepatol. 2009 Oct;3(5):465-7. doi: 10.1586/egh.09.41. No abstract available.

PMID:
19817667
6.

Metformin for liver cancer prevention in patients with type 2 diabetes: a systematic review and meta-analysis.

Zhang ZJ, Zheng ZJ, Shi R, Su Q, Jiang Q, Kip KE.

J Clin Endocrinol Metab. 2012 Jul;97(7):2347-53. doi: 10.1210/jc.2012-1267. Epub 2012 Apr 20. Review.

PMID:
22523334
7.

Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: potential role of insulin.

Donadon V, Balbi M, Casarin P, Vario A, Alberti A.

World J Gastroenterol. 2008 Oct 7;14(37):5695-700.

8.

Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease.

Donadon V, Balbi M, Ghersetti M, Grazioli S, Perciaccante A, Della Valentina G, Gardenal R, Dal Mas M, Casarin P, Zanette G, Miranda C.

World J Gastroenterol. 2009 May 28;15(20):2506-11.

9.

Metformin therapy and its anti-neoplastic role in systemic malignancies besides hepatocellular carcinomas.

Kapoor S.

Scand J Gastroenterol. 2013 May;48(5):636-7. doi: 10.3109/00365521.2013.777773. Epub 2013 Mar 11. No abstract available.

PMID:
23477305
10.

Metformin associated with lower mortality in diabetic patients with early stage hepatocellular carcinoma after radiofrequency ablation.

Chen TM, Lin CC, Huang PT, Wen CF.

J Gastroenterol Hepatol. 2011 May;26(5):858-65. doi: 10.1111/j.1440-1746.2011.06664.x.

PMID:
21251068
11.

Mysterious metformin.

Chong CR, Chabner BA.

Oncologist. 2009 Dec;14(12):1178-81. doi: 10.1634/theoncologist.2009-0286. Epub 2009 Dec 10. No abstract available.

12.

Editorial: hepatocellular carcinoma in type 2 diabetes: more than meets the eye.

Baffy G.

Am J Gastroenterol. 2012 Jan;107(1):53-5. doi: 10.1038/ajg.2011.390.

PMID:
22218030
13.

Mechanisms of metformin action in non-insulin-dependent diabetes mellitus.

Perriello G.

Diabetes Metab Rev. 1995 Sep;11 Suppl 1:S51-6. Review. No abstract available.

PMID:
8529485
14.

Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis.

Zhang H, Gao C, Fang L, Zhao HC, Yao SK.

Scand J Gastroenterol. 2013 Jan;48(1):78-87. doi: 10.3109/00365521.2012.719926. Epub 2012 Nov 9.

PMID:
23137049
15.

Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study.

Lai SW, Chen PC, Liao KF, Muo CH, Lin CC, Sung FC.

Am J Gastroenterol. 2012 Jan;107(1):46-52. doi: 10.1038/ajg.2011.384. Epub 2011 Nov 15.

PMID:
22085817
16.

Interferon therapy reduces the risk for hepatocellular carcinoma.

Brown JL.

Gut. 2000 Nov;47(5):610-1. No abstract available.

17.

[Hepatocellular carcinoma - metformin reduces the risk of type 2 diabetes in a dose-dependent manner].

[No authors listed]

Z Gastroenterol. 2013 Aug;51(8):716. German. No abstract available.

PMID:
24298628
18.

Metformin: fifty-two not out.

Campbell IW.

J Indian Med Assoc. 2009 Nov;107(11):779-84. Review. No abstract available.

PMID:
20469782
19.

Metformin and the intestine.

Bailey CJ, Wilcock C, Scarpello JH.

Diabetologia. 2008 Aug;51(8):1552-3. doi: 10.1007/s00125-008-1053-5. Epub 2008 Jun 5. No abstract available.

PMID:
18528677
20.

Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials.

Lamanna C, Monami M, Marchionni N, Mannucci E.

Diabetes Obes Metab. 2011 Mar;13(3):221-8. doi: 10.1111/j.1463-1326.2010.01349.x.

PMID:
21205121
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk